Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α.
Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs.
Madariaga Virus Infection Associated with a Case of Acute Disseminated Encephalomyelitis.
Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls.
Cdon, a cell surface protein, mediates oligodendrocyte differentiation and myelination.
Certified occupational therapy assistants.
Advances in understanding the pathogenesis of autoimmune disorders: focus on chemokines and lymphocyte trafficking.
Systematic review of occupational therapy-related interventions for people with multiple sclerosis: part 1. Activity and participation.
The Involvement of Calpain in CD4(+) T Helper Cell Bias in Multple Sclerosis.
Perceptions of using videogames in rehabilitation: a dual perspective of people with multiple sclerosis and physiotherapists.
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis.
Switching Therapies in Multiple Sclerosis.
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
The expanded spectrum of neuromyelitis optica: evidences for a new definition.
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world.
Symptoms Related to Tumor Necrosis Factor Receptor 1-associated Periodic Syndrome, Multiple Sclerosis, and Severe Rheumatoid Arthritis in Patients Carrying the TNF Receptor Superfamily 1A D12E/p.Asp41Glu Mutation.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
Role of TRIF Small Interference RNA (siRNA) in Chronic Experimental Allergic Encephalomyelitis (EAE).
[Difficulties experienced at work by patients with multiple sclerosis].
Simvastatin: Multiple Sclerosis.
Brain ageing and disorders of the central nervous system: kynurenines and drug metabolism.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
The Perspectives of Iranian Patients With Multiple Sclerosis on Continuity of Care: A Qualitative Study.
Is There A Pulse Wave Encephalopathy Component To Multiple Sclerosis?
Pages
« first
‹ previous
…
450
451
452
453
454
455
456
457
458
…
next ›
last »